Fengying Wu

4.2k total citations
97 papers, 1.8k citations indexed

About

Fengying Wu is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Fengying Wu has authored 97 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Oncology, 47 papers in Pulmonary and Respiratory Medicine and 23 papers in Molecular Biology. Recurrent topics in Fengying Wu's work include Lung Cancer Treatments and Mutations (33 papers), Lung Cancer Research Studies (20 papers) and Cancer Immunotherapy and Biomarkers (19 papers). Fengying Wu is often cited by papers focused on Lung Cancer Treatments and Mutations (33 papers), Lung Cancer Research Studies (20 papers) and Cancer Immunotherapy and Biomarkers (19 papers). Fengying Wu collaborates with scholars based in China, United States and Taiwan. Fengying Wu's co-authors include Caicun Zhou, Lei Wang, Shengxiang Ren, Guanghui Gao, Fei Zhou, Chunxia Su, Tao Jiang, Xuefei Li, Chao Zhao and Viola W. Zhu and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Fengying Wu

88 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fengying Wu China 22 988 906 538 283 178 97 1.8k
Guanghui Gao China 30 1.5k 1.5× 1.4k 1.5× 811 1.5× 620 2.2× 170 1.0× 86 2.5k
Siyu Wang China 21 631 0.6× 890 1.0× 274 0.5× 200 0.7× 94 0.5× 131 1.5k
Yoon Ho Ko South Korea 23 514 0.5× 375 0.4× 591 1.1× 401 1.4× 136 0.8× 103 1.5k
Eric T. Kimchi United States 27 1.1k 1.1× 504 0.6× 588 1.1× 382 1.3× 332 1.9× 103 2.1k
Philipp Nuhn Germany 21 433 0.4× 978 1.1× 656 1.2× 427 1.5× 82 0.5× 104 1.8k
Nicola Battelli Italy 23 1.0k 1.0× 814 0.9× 512 1.0× 553 2.0× 274 1.5× 91 1.9k
Yiwei Huang China 22 621 0.6× 756 0.8× 803 1.5× 524 1.9× 221 1.2× 68 1.7k
Rohan Garje United States 17 1.1k 1.1× 556 0.6× 429 0.8× 249 0.9× 422 2.4× 79 1.8k

Countries citing papers authored by Fengying Wu

Since Specialization
Citations

This map shows the geographic impact of Fengying Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengying Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengying Wu more than expected).

Fields of papers citing papers by Fengying Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fengying Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengying Wu. The network helps show where Fengying Wu may publish in the future.

Co-authorship network of co-authors of Fengying Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Fengying Wu. A scholar is included among the top collaborators of Fengying Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fengying Wu. Fengying Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Pan, Shulei, Fengying Wu, Ning Wang, et al.. (2025). MMAE-Based Peptide–Drug Conjugates Targeting GPC3 for Precision Chemoradiotherapy in Hepatocellular Carcinoma. Journal of Medicinal Chemistry. 68(12). 12950–12968. 1 indexed citations
3.
Zhang, Xiaoshen, Yaokai Wen, Fengying Wu, et al.. (2025). GSTA1 Conferred Tolerance to Osimertinib and Provided Strategies to Overcome Drug-Tolerant Persister in EGFR-Mutant Lung Adenocarcinoma. Journal of Thoracic Oncology. 21(3). 103494–103494.
4.
Liu, Xiaozhen, Shiqi Mao, Chuchu Shao, et al.. (2025). BIRC5 expression correlates with immunosuppressive phenotype and predicts inferior response to immunotherapy in lung adenocarcinoma. Journal of Thoracic Disease. 17(8). 5921–5935.
5.
Liu, Lianyong, Fengying Wu, Chenxi Li, et al.. (2025). Delineating unique MASH-endothelial cells in metabolic dysfunction-associated steatotic liver disease using single-cell lensing. Digestive and Liver Disease. 57(10). 1974–1984.
6.
Liu, Ye, Lifan Zhang, Yan Chen, et al.. (2024). Incidence and Risk Factors of Active Tuberculosis Among Hospitalized Patients with Latent Tuberculosis Infection in China: A Cohort Study. Infection and Drug Resistance. Volume 17. 953–960. 1 indexed citations
7.
Zhou, Fangwei, et al.. (2024). Identification of the Optimal Quantitative RT-PCR Reference Gene for Paper Mulberry (Broussonetia papyrifera). Current Issues in Molecular Biology. 46(10). 10779–10794. 3 indexed citations
8.
Wu, Fengying, et al.. (2024). Efficient ultrasonic extraction of alkaloids and glycosides from Camptotheca acuminata Decne via deep eutectic solvents: Kinetics and mechanisms. Separation and Purification Technology. 356. 129771–129771. 3 indexed citations
9.
Sun, Yu, Jie Zhang, Zhiming Zhao, et al.. (2024). The deubiquitinase USP2a promotes tumor immunosuppression by stabilizing immune checkpoint B7–H4 in lung adenocarcinoma harboring EGFR-activating mutants. Cancer Letters. 596. 217020–217020. 3 indexed citations
10.
Xiu, Weigang, Yuwen Zhou, He Du, et al.. (2023). A nomogram for the prediction of the survival of patients with advanced non‐small cell lung cancer and interstitial lung disease. Cancer Medicine. 12(10). 11375–11384. 3 indexed citations
11.
Li, Hao, et al.. (2023). Effective adsorption of bisphenol A from aqueous solution using phosphoric acid-assisted hydrochar. Environmental Science and Pollution Research. 30(59). 123083–123097. 1 indexed citations
12.
13.
Liu, Yuchen, et al.. (2023). Identification and validation of a pyroptosis-related signature in identifying active tuberculosis via a deep learning algorithm. Frontiers in Cellular and Infection Microbiology. 13. 1273140–1273140. 6 indexed citations
14.
Wu, Fengying, Yue Zeng, Yujun Li, et al.. (2023). 1843MO The effect of chronic psychological stress on the efficacy of first-line therapy of ICIs in advanced NSCLC (STRESS-LUNG-1 trial). Annals of Oncology. 34. S999–S999. 1 indexed citations
15.
Zhou, Fei, Haoyue Guo, Xiaolong Zhou, et al.. (2022). Immune checkpoint inhibitors plus chemotherapy in patients with locally advanced or metastatic pulmonary sarcomatoid carcinoma: a multicentric real-world study. Therapeutic Advances in Medical Oncology. 14. 4287548791–4287548791. 10 indexed citations
16.
Gong, Xiangyi, et al.. (2022). Rapid uptake of Pb(II) in water by β-cyclodextrin functionalized sycamore leaf-based biochar. Desalination and Water Treatment. 278. 129–140. 4 indexed citations
17.
Ye, Lingyun, Yan Huang, Fei Zhou, et al.. (2022). Characteristics of Notch signaling pathway and its correlation with immune microenvironment in SCLC. Lung Cancer. 167. 25–33. 18 indexed citations
18.
Mao, Shiqi, Fei Zhou, Yiwei Liu, et al.. (2021). ICI plus chemotherapy prolonged survival over ICI alone in patients with previously treated advanced NSCLC. Cancer Immunology Immunotherapy. 71(1). 219–228. 7 indexed citations
19.
Liu, Yiwei, Zhengwei Dong, Tao Jiang, et al.. (2018). Heterogeneity of PD-L1 Expression Among the Different Histological Components and Metastatic Lymph Nodes in Patients With Resected Lung Adenosquamous Carcinoma. Clinical Lung Cancer. 19(4). e421–e430. 43 indexed citations
20.
Liu, Yanbiao, Shengxiang Ren, Yingying Peng, et al.. (2017). The heterogeneity of PD-L1 expression among the different histological components and metastatic lymph nodes in patients with resected lung adenosquamous carcinoma. Annals of Oncology. 28. x119–x120. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guanghui Gao Breakdown of academic impact, for papers by Siyu Wang Breakdown of academic impact, for papers by Yoon Ho Ko Breakdown of academic impact, for papers by Eric T. Kimchi Breakdown of academic impact, for papers by Philipp Nuhn Breakdown of academic impact, for papers by Nicola Battelli Breakdown of academic impact, for papers by Yiwei Huang Breakdown of academic impact, for papers by Rohan Garje
Rankless by CCL
2026